A multicenter study in mexico finds acinetobacter baumannii clinical isolates belonging to clonal complexes 636B (113B) and 92B harboring OXA-72, OXA-239, and OXA-469

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 4, 2016, Pages 2587-2588

  Gonzalez Villoria, Ana M ^a   Tamayo Legorreta, Elsa ^a   Garza Ramos, Ulises ^a   Barrios, Humberto ^a   Sanchez Pérez, Alejandro ^a   Rodríguez Medina, Nadia ^a   Uribe Aviña, Naville ^a   Cevallos, Miguel A ^b   Silva Sanchez, Jesus ^a   Garza Gonzalez E ^c   Gonzalez G M ^c   Salazar, Juana ^d   Hurtado Montalvo, J A ^e   Meza Chavez A ^f   Diaz Ramos, R D ^f   Galicia, A ^f   Perez Carranco, M L ^f   Diaz Pena R ^g   Del Nino Moreno P C ^h   Turrubiates Martinez E A ^h   Tovar Oviedo, J ^h   Magana Aquino M ^h   Loperena Contreras, L E ⁱ   Rivera Martinez N E ^j   Cruz Martinez Q S ^j   Ayala Gaytan, J ^k   Guajardo Lara, C E ^k   Santacruz Tinoco, C E ^l   Cornejo, Patricia ^m   Volkow, Patricia ^m   Morfin Otero, R ⁿ   Rodriguez Noriega, E ⁿ   Calderon A ^o   Jaimes Dominguez F ^o   Gonzalez Cervantes B ^o   Gonzalez Martinez M R ^p   Vazquez Farias, M ^p   Serrano Osuna, R ^q   Miranda Romero, A L ^q   more..

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

^c Hospital Universitario de Nuevo León   (Mexico)

^d Centro Médico Nacional 20 de Noviembre   (Mexico)

^e Hospital General de Tijuana   (Mexico)

^f INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^g Pediatría Centro Médico Nacional de Oriente   (Mexico)

^h Autonomous San Luis Potosi University   (Mexico)

ⁱ Hospital General de Uruapan   (Mexico)

^j HOSPITAL REGIONAL DE ALTA ESPECIALIDAD DE OAXACA   (Mexico)

^k SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^l Hospital La Raza Centro Médico Nacional   (Mexico)

^m INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

ⁿ HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^o Hospital General de Acapulco   (Mexico)

^p Unidad Médica de Alta Especialidad de Torreón   (Mexico)

^q Unidad Médica de Alta Especialidad de Ciudad Obregón   (Mexico)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; COLISTIN; IMIPENEM; MEROPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; ISOENZYME; OXA-72 CARBAPENEMASE, ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; BACTERIUM ISOLATE; LETTER; MEXICO; MULTICENTER STUDY (TOPIC); NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; ACINETOBACTER INFECTIONS; ANTIBIOTIC RESISTANCE; CELL CLONE; CLASSIFICATION; CLINICAL TRIAL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HEALTH SURVEY; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTICENTER STUDY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CLONE CELLS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE EXPRESSION; HOSPITALS; HUMANS; ISOENZYMES; MEXICO; MICROBIAL SENSITIVITY TESTS; PUBLIC HEALTH SURVEILLANCE;

EID: 84963570144     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02042-15     Document Type: Letter

References (8)

1. Bocanegra-Ibarias P, Pena-Lopez C, Camacho-Ortiz A, Llaca-Diaz J, Silva-Sanchez J, Barrios H, Garza-Ramos U, Rodriguez-Flores AM, Garza-Gonzalez E. 2015. Genetic characterisation of drug resistance and clonal dynamics of Acinetobacter baumannii in a hospital setting in Mexico. Int J Antimicrob Agents 45:309 -313. http://dx.doi.org/10.1016/j.ijantimicag.2014.10.022.
2. Tamayo-Legorreta E, Garza-Ramos U, Barrios-Camacho H, Sanchez- Perez A, Galicia-Paredes A, Meza-Chavez A, Silva-Sanchez J. 2014. Identification of OXA-23 carbapenemases: novel variant OXA-239 in Acinetobacter baumannii ST758 clinical isolates in Mexico. New Microbes New Infect 2:173-174. http://dx.doi.org/10.1002/nmi2.60.
3. Higgins PG, Pérez-Llarena FJ, Zander E, Fernández A, Bou G, Seifert H. 2013. OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chem 57:2121- 2126. http://dx.doi.org/10.1128/AAC.02413-12.
4. Morfín-Otero R, Alcántar-Curiel M, Rocha M, Alpuche-Aranda C, Santos- Preciado J, Gayosso-Vázquez C, Araiza-Navarro J, Flores-Vaca M, Esparza-Ahumada S, González-Díaz E. 2013. Acinetobacter baumannii infections in a tertiary care hospital in Mexico over the past 13 years. Chemotherapy 59:57-65. http://dx.doi.org/10.1159/000351098.
5. CLSI. 2015. Performance standards for antimicrobial susceptibility testing; 25th informational supplement. M100-S25. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresisgenerated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43: 4328-4335. http://dx.doi.org/10.1128/JCM.43.9.4328-4335.2005.
7. Dortet L, Poirel L, Errera C, Nordmann P. 2014. CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp. J Clin Microbiol 52:2359-2364. http://dx.doi.org/10.1128/JCM.00594-14.
8. Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B. 2009. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 155: 2333-2341. http://dx.doi.org/10.1099/mic.0.026054-0.